Last updated: September 17, 2022
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Eye Disease
Eye Disorders/infections
Treatment
N/AClinical Study ID
NCT05512572
2021-0563
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients had primary or recurrent eyelid plate gland cyst without obvious surgicalindications
Exclusion
Exclusion Criteria:
- (1) any intraocular inflammation, ocular infection, allergy, ocular surgery, or oculartrauma in the past 6 months; (2) any eyelid diseases or structural abnormality; (3)any systematic diseases may lead to dry eye or MGD; (4) skin cancer or pigmentedlesion in the treatment zone.
Study Design
Total Participants: 80
Study Start date:
August 23, 2021
Estimated Completion Date:
August 23, 2023
Connect with a study center
Second Affiliated Hospital of Zhejiang University Hospital
Hangzhou, Zhejiang
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.